Jane Xia

Jane Xia is currently the Director, Trofinetide Launch Insights Lead at Acadia Pharmaceuticals Inc. In their previous roles, Jane excelled as the SVP Commercial Planning and Business Development at Transcenta, where Jane led key assets commercial strategy development and built commercialization capabilities. With over 15 years of experience in various leadership roles at companies such as Amgen, Bristol-Myers Squibb, and Baxter BioScience, Jane has a strong background in market monitoring, competitive intelligence, and business analysis. Jane holds an MBA from USC Marshall School of Business.